Variant report

Variant	nsv971480
Chromosome Location	chr7:2755767-2765866
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:37)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:37 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr18:33161346..33162077-chr7:2758154..2758655,2	HCT-116	colon:
2	chr7:2755108..2758694-chr7:2796336..2799311,5	K562	blood:
3	chr7:2758388..2761774-chr7:2912256..2915270,3	K562	blood:
4	chr7:2757306..2759067-chr7:2759260..2762192,2	K562	blood:
5	chr7:2751778..2761552-chr7:2768388..2775125,13	K562	blood:
6	chr7:2755108..2759929-chr7:2796424..2799629,5	K562	blood:
7	chr7:2749256..2751916-chr7:2756659..2758882,3	K562	blood:
8	chr7:2724386..2733394-chr7:2753206..2761980,25	MCF-7	breast:
9	chr10:112773361..112773861-chr7:2758450..2759306,2	MCF-7	breast:
10	chr7:2727234..2729043-chr7:2757444..2760192,2	MCF-7	breast:
11	chr7:2593899..2596439-chr7:2755739..2757666,2	K562	blood:
12	chr7:2758216..2760821-chr7:2762447..2764162,2	K562	blood:
13	chr7:2760677..2762584-chr7:2771267..2773265,2	MCF-7	breast:
14	chr7:2739959..2741756-chr7:2757335..2758890,2	MCF-7	breast:
15	chr7:2695858..2698224-chr7:2755632..2757966,2	K562	blood:
16	chr7:2758294..2760218-chr7:2772871..2774400,2	MCF-7	breast:
17	chr7:2756196..2760316-chr7:2775723..2779597,5	K562	blood:
18	chr7:2763542..2765998-chr7:2913273..2914846,2	MCF-7	breast:
19	chr7:2710355..2711188-chr7:2758257..2758996,5	MCF-7	breast:
20	chr7:2749908..2752648-chr7:2759444..2761951,3	MCF-7	breast:
21	chr7:2757202..2759716-chr7:2762662..2764833,2	K562	blood:
22	chr7:2757306..2759067-chr7:2759260..2762192,2	K562	blood:
23	chr7:2758129..2761976-chr7:2763173..2766287,3	MCF-7	breast:
24	chr7:2747802..2752072-chr7:2752381..2756617,8	K562	blood:
25	chr7:2760749..2763045-chr7:2764793..2766522,2	K562	blood:
26	chr7:2650921..2653062-chr7:2755839..2758657,2	MCF-7	breast:
27	chr7:2756029..2757761-chr7:2771814..2773662,2	MCF-7	breast:
28	chr7:2393560..2395423-chr7:2757362..2759137,2	K562	blood:
29	chr7:2757202..2759716-chr7:2762662..2764833,2	K562	blood:
30	chr7:2758129..2761976-chr7:2763173..2766287,3	MCF-7	breast:
31	chr7:2760749..2763045-chr7:2764793..2766522,2	K562	blood:
32	chr7:2761837..2763894-chr7:2912353..2913943,2	MCF-7	breast:
33	chr7:2710494..2711221-chr7:2758292..2759192,2	MCF-7	breast:
34	chr7:2758216..2760821-chr7:2762447..2764162,2	K562	blood:
35	chr7:2760607..2761112-chr7:2860852..2861356,2	MCF-7	breast:
36	chr7:2729178..2731029-chr7:2755632..2757456,2	MCF-7	breast:
37	chr7:2756357..2758230-chr7:2913588..2915207,2	K562	blood:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GNA12-1	chr7:2761466-2761772	XLOC_006336
2	lnc-TTYH3-2	chr7:2762818-2764609	NONHSAT118823
3	lnc-GNA12-1	chr7:2763099-2764726	XLOC_006336
4	lnc-GNA12-2	chr7:2757467-2760269	XLOC_006335
5	lnc-GNA12-2	chr7:2762138-2762622	XLOC_006335

No data

Variant related genes	Relation type
ENSG00000106009	chromatin interactions
ENSG00000106266	chromatin interactions
ENSG00000141429	chromatin interactions
ENSG00000106263	chromatin interactions
ENSG00000174945	chromatin interactions

Extended variants
information (count: 699 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:699 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs577023353	chr7:2755782-2755783	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs546057634	chr7:2755829-2755830	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs559632430	chr7:2755854-2755855	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs145005560	chr7:2755887-2755888	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs148521873	chr7:2755888-2755889	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs536744354	chr7:2755905-2755906	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs7802871	chr7:2755916-2755917	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs543107132	chr7:2755918-2755919	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs561624703	chr7:2755923-2755924	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs530669876	chr7:2755961-2755962	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs118140750	chr7:2755963-2755964	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs564245885	chr7:2756003-2756004	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs142882505	chr7:2756021-2756022	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs117587677	chr7:2756025-2756026	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs188035457	chr7:2756036-2756037	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs191339021	chr7:2756070-2756071	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs147658723	chr7:2756085-2756086	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs114440193	chr7:2756087-2756088	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs537504281	chr7:2756097-2756098	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs576986513	chr7:2756101-2756102	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs572122417	chr7:2756106-2756107	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs184551210	chr7:2756116-2756117	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs553229413	chr7:2756117-2756118	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs189335897	chr7:2756123-2756124	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs541450389	chr7:2756131-2756132	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs3830624	chr7:2756140-2756141	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs35029978	chr7:2756141-2756142	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs531679217	chr7:2756143-2756144	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs397736878	chr7:2756144-2756145	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs201573352	chr7:2756145-2756146	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs575154477	chr7:2756150-2756151	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs564114884	chr7:2756163-2756164	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs182580880	chr7:2756201-2756202	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs564204645	chr7:2756236-2756237	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs533141689	chr7:2756249-2756250	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs546866387	chr7:2756264-2756265	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs115178728	chr7:2756269-2756270	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs186700239	chr7:2756288-2756289	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs117899828	chr7:2756307-2756308	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs568412792	chr7:2756308-2756309	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs537062691	chr7:2756318-2756319	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs190366133	chr7:2756319-2756320	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs181195551	chr7:2756322-2756323	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs186657366	chr7:2756331-2756332	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs553190458	chr7:2756332-2756333	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs375522781	chr7:2756341-2756342	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs189721745	chr7:2756361-2756362	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs182338323	chr7:2756394-2756395	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs575161199	chr7:2756395-2756396	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs539403807	chr7:2756401-2756402	Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Acute myeloid leukemia	19651601	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Cancer	17160897	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Chordoma	21602918	CNVD
Lynch syndrome	22585707	CNVD
Follicular lymphoma	20505157	CNVD
Breast cancer	16397240	CNVD
Raine Syndrome	17924334	CNVD
Diffuse large b-cell lymphoma	21266526	CNVD
Melanoma	18172304	CNVD
Sudden cardiac death	19188705	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Glioma	18556773	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17142309	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21509527	CNVD
Nasopharyngeal cancer	20548289	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
Spondylocostal dysostosis	21085971	CNVD
Mental retardation	17901693	CNVD
Heart disease	21282601	CNVD
Glioblastoma multiforme	22286061	CNVD
lymphocytic leukemia	21291569	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:567 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:2742200-2765600	Weak transcription	HSMM	muscle
2	chr7:2749000-2760800	Genic enhancers	Primary hematopoietic stem cells short term culture	blood
3	chr7:2749400-2770600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr7:2749800-2757600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
5	chr7:2749800-2758000	Weak transcription	Brain Anterior Caudate	brain
6	chr7:2749800-2759800	Weak transcription	HMEC	breast
7	chr7:2749800-2770800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr7:2750000-2757200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr7:2750000-2757400	Weak transcription	Muscle Satellite Cultured Cells	--
10	chr7:2750000-2760400	Weak transcription	Hela-S3	cervix
11	chr7:2750000-2760800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr7:2750000-2762800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr7:2750000-2765600	Weak transcription	Brain Substantia Nigra	brain
14	chr7:2750000-2767800	Weak transcription	Osteobl	bone
15	chr7:2750000-2768400	Weak transcription	Placenta Amnion	Placenta Amnion
16	chr7:2750000-2769000	Weak transcription	NHDF-Ad	bronchial
17	chr7:2750200-2756200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
18	chr7:2750200-2757600	Weak transcription	HepG2	liver
19	chr7:2750200-2757800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr7:2750200-2765800	Weak transcription	Liver	Liver
21	chr7:2751000-2756200	Weak transcription	Duodenum Mucosa	Duodenum
22	chr7:2751000-2756200	Weak transcription	Rectal Mucosa Donor 31	rectum
23	chr7:2751000-2756400	Weak transcription	Esophagus	oesophagus
24	chr7:2751000-2756600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
25	chr7:2751000-2756600	Weak transcription	Sigmoid Colon	Sigmoid Colon
26	chr7:2751000-2759000	Enhancers	Fetal Heart	heart
27	chr7:2751000-2764400	Weak transcription	Brain Germinal Matrix	brain
28	chr7:2751200-2755800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr7:2751200-2756600	Strong transcription	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr7:2751200-2768400	Weak transcription	Brain Angular Gyrus	brain
31	chr7:2751800-2757800	Enhancers	Left Ventricle	heart
32	chr7:2752200-2755800	Enhancers	Fetal Muscle Leg	muscle
33	chr7:2752400-2758400	Genic enhancers	Placenta	Placenta
34	chr7:2752400-2796000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr7:2752800-2757600	Enhancers	Fetal Muscle Trunk	muscle
36	chr7:2753200-2756200	Strong transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
37	chr7:2753200-2756800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr7:2753400-2760400	Weak transcription	Aorta	Aorta
39	chr7:2753400-2765800	Weak transcription	Brain Inferior Temporal Lobe	brain
40	chr7:2753600-2756000	Genic enhancers	Fetal Lung	lung
41	chr7:2753600-2759200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
42	chr7:2753600-2768800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr7:2753800-2755800	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
44	chr7:2753800-2756200	Weak transcription	Lung	lung
45	chr7:2753800-2757000	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr7:2753800-2758200	Strong transcription	Cortex derived primary cultured neurospheres	brain
47	chr7:2753800-2760400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
48	chr7:2754000-2756600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
49	chr7:2754000-2756800	Weak transcription	HUVEC	blood vessel
50	chr7:2754000-2757800	Weak transcription	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links